CHO Pharma, Inc. (TPEX:6586)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
85.00
-4.80 (-5.35%)
Nov 17, 2026, 2:00 PM CST

CHO Pharma Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
18,1916,01411,02214,83025,20415,354
Market Cap Growth
182.86%-45.44%-25.68%-41.16%64.15%235.65%
Enterprise Value
16,2383,8098,56813,94424,03313,969
Last Close Price
85.4028.1051.5069.30137.0083.50

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
10669.154202.443078.64-420067.124300.98
PB Ratio
7.672.444.014.9917.648.80
P/TBV Ratio
9.312.944.745.8327.0612.44

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-2661.502393.25-400545.333912.99

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.000.010.01-0.010.02
Net Debt / Equity Ratio
-0.82-0.83-0.85-0.87-0.72-0.74
Net Debt / EBITDA Ratio
6.686.539.8310.403.186.99
Net Debt / FCF Ratio
7.827.0810.498.883.996.59
Asset Turnover
0.000.000.00-00.00
Quick Ratio
21.3218.9620.4124.576.199.89
Current Ratio
21.9619.4720.8124.936.3910.06
Return on Equity (ROE)
-10.71%-11.13%-7.41%-13.90%-21.33%-11.11%
Return on Assets (ROA)
-7.24%-7.47%-5.22%-7.17%-12.55%-6.52%
Return on Capital Employed (ROCE)
-12.70%-13.20%-9.00%-9.00%-24.50%-12.00%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-1.48%-4.82%-1.93%-2.06%-1.34%-1.34%
FCF Yield
-1.37%-4.80%-2.02%-1.98%-1.03%-1.28%
Buyback Yield / Dilution
---11.86%-4.00%-0.04%-0.12%